Literature DB >> 16616271

Nonsteroidal anti-inflammatory drugs.

Carin E Dugowson1, Priya Gnanashanmugam.   

Abstract

Nonsteroidal anti-inflammatory drugs, including COX-2 selective drugs, are often used for acute and chronic musculoskeletal pain,including osteoarthritis, trauma, overuse syndromes, and compression fractures. Although these medications are often well tolerated in the young and otherwise healthy patient, the chronic use of these medications can lead to multiple medical problems, most commonly related to the gastrointestinal tract. Recently, concerns about cardiovascular adverse effects have been raised, particularly in the COX-2 drugs. Dosing and duration of therapy should be adjusted for comorbidities. CBC and renal and hepatic function should be checked at intervals of 3 to 6 months, depending on the patient.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16616271     DOI: 10.1016/j.pmr.2005.12.012

Source DB:  PubMed          Journal:  Phys Med Rehabil Clin N Am        ISSN: 1047-9651            Impact factor:   1.784


  15 in total

1.  Study of Binding Properties Between Two New Ibuprofen and Naproxen Based Acyl Hydrazone Derivatives and Trypsin.

Authors:  Elmas Gökoğlu; Esra Yılmaz; Esra Gökoğlu; Ayşe Uzgören Baran
Journal:  J Fluoresc       Date:  2016-01       Impact factor: 2.217

2.  Potency of non-steroidal anti-inflammatory drugs in chemotherapy.

Authors:  Lucia Hiľovská; Rastislav Jendželovský; Peter Fedoročko
Journal:  Mol Clin Oncol       Date:  2014-10-16

3.  Interaction of indomethacin with calf thymus DNA: a multi-spectroscopic, thermodynamic and molecular modelling approach.

Authors:  Mohammed Amir Husain; Hassan Mubarak Ishqi; Tarique Sarwar; Sayeed Ur Rehman; Mohammad Tabish
Journal:  Medchemcomm       Date:  2017-04-27       Impact factor: 3.597

4.  Randomized, double-blind, Placebo-Controlled Study to Compare the Efficacy of Combination of Lidocaine with ketorolac or triamcinolone versus Lidocaine Alone for Soft Tissue Injuries.

Authors:  Bura Sindhupakorn; Darawan Jomkoh; Theeranit Namkuntee
Journal:  J Orthop       Date:  2020-01-28

5.  Soft tissue injections in the athlete.

Authors:  Jeffrey J Nepple; Matthew J Matava
Journal:  Sports Health       Date:  2009-09       Impact factor: 3.843

Review 6.  Foot and Ankle Injections in Athletes.

Authors:  Jonathan K Ochoa; Christopher E Gross; Robert B Anderson; Andrew R Hsu
Journal:  Sports Health       Date:  2021-03-24       Impact factor: 4.355

7.  Effect of cyclooxygenase inhibition on cholesterol efflux proteins and atheromatous foam cell transformation in THP-1 human macrophages: a possible mechanism for increased cardiovascular risk.

Authors:  Edwin S L Chan; Hongwei Zhang; Patricia Fernandez; Sari D Edelman; Michael H Pillinger; Louis Ragolia; Thomas Palaia; Steven Carsons; Allison B Reiss
Journal:  Arthritis Res Ther       Date:  2007       Impact factor: 5.156

8.  Injectable Ketorolac and Corticosteroid Use in Athletes: A Systematic Review.

Authors:  Timothy R Jelsema; Anthony C Tam; James L Moeller
Journal:  Sports Health       Date:  2020-09-02       Impact factor: 3.843

9.  Efficacy of intra-articular hyaluronan (Synvisc(R)) for the treatment of osteoarthritis affecting the first metatarsophalangeal joint of the foot (hallux limitus): study protocol for a randomised placebo controlled trial.

Authors:  Shannon E Munteanu; Hylton B Menz; Gerard V Zammit; Karl B Landorf; Christopher J Handley; Ayman Elzarka; Jason Deluca
Journal:  J Foot Ankle Res       Date:  2009-01-16       Impact factor: 2.303

10.  Dendrimer-coupled sonophoresis-mediated transdermal drug-delivery system for diclofenac.

Authors:  Bin Huang; Wei-Jiang Dong; Gao-Yi Yang; Wei Wang; Cong-Hua Ji; Fei-Ni Zhou
Journal:  Drug Des Devel Ther       Date:  2015-07-23       Impact factor: 4.162

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.